Covid-19 Plasma Registry
Seeking people, local to central Massachusetts, who are fully recovered from the new coronavirus to sign up to donate plasma to help current COVID-19 patients.
Seeking people, local to central Massachusetts, who are fully recovered from the new coronavirus to sign up to donate plasma to help current COVID-19 patients.
Seeking men and women who are at high risk of developing COVID-19 following an exposure to an infected person for a study to evaluate whether convalescent plasma, which is made from blood donated from a person who has recovered from COVID-19, might prevent or lessen the severity of COVID-19.
Seeking men and women who are being treated outside of the hospital for their COVID-19 infection for a study of an investigational blood product made from blood plasma donated by people who have recovered from COVID-19, known as convalescent plasma.
Seeking people aged 12 and older who have been diagnosed with COVID-19 for an experimental treatment made from blood donated by people who have recovered from COVID-19.
Seeking men and women with mild to moderate COVID-19 infection to investigate the potential benefits of a specially formulated probiotic to treat gastrointestinal symptoms related to COVID-19.
Seeking boys and girls under the age of 18 who are hospitalized for a COVID-19 infection for a study of the safety and effectiveness of remdesivir for COVID-19 infection in children.
Seeking individuals over 12 years of age with mild to moderate COVID-19 illness, but have not yet been hospitalized for a study of investigational monoclonal antibodies against COVID-19.
Seeking men and women aged 18 and older who have been hospitalized for COVID-19 for a study of an experimental treatment using Hyperimmune Intravenous Immunoglobulin containing antibodies for COVID-19.
Seeking men and women with mild to moderate COVID-19 for a study of an investigational drug that contains monoclonal antibodies.
Seeking men and women who have been hospitalized with COVID-19 for a study that compares the safety and activity of experimental regimens consisting of oral anti-inflammatory agents plus Remdesivir.
Seeking adults and children for a study testing the accuracy of investigational devices to diagnose COVID-19.